The FDA’s approval of Voyxact for IgA nephropathy, based on Phase 3 trial data showing a 40% reduction in eGFR…
Memorial Sloan Kettering’s AI clinical trial data shows improved patient matching and operational efficiency
Memorial Sloan Kettering’s AI system achieved 100% accuracy in patient matching for clinical trials, identifying all manually screened candidates and…
What FDA leadership votes mean for drug approval transparency
Recent FDA decisions under the National Priority Voucher program have raised concerns about political influence in scientific drug approvals. A…
How AI cybersecurity reduces healthcare breach detection times by over 50%
AI is transforming healthcare cybersecurity by cutting data breach detection times significantly, as shown in recent studies. This analysis covers…
What FDA and WHO vaccine regulatory updates mean for public health outcomes
This article examines recent FDA and WHO proposals to update vaccine ingredients and schedules, based on clinical evidence from studies…
What FDA’s CRISPR approvals mean for rare disease economics
The FDA’s 2023 approval of CRISPR therapies for sickle cell disease and beta-thalassemia highlights clinical benefits like reduced crises and…
Strategic Integration of Cybersecurity in Healthcare: A Patient Safety Imperative
This article explores how cybersecurity is being embedded into healthcare strategy through collaboration and AI tools, based on recent surveys…
AI Advances Personalized Medicine and Cuts Drug Development Costs
Artificial intelligence is transforming medicine by enabling personalized therapies and reducing drug development expenses from over $2.6 billion per drug.…
AI therapy apps boom amid regulatory gray zone, raising safety concerns
The rapid growth of AI mental health chatbots faces scrutiny over privacy violations and unvalidated advice, highlighting a critical lack…
The Unregulated Frontier of AI Mental Health Chatbots Poses Significant Risks
The booming AI mental health app market faces a critical lack of oversight, exposing users to privacy breaches and potentially…
Synchron wins FDA approval for breakthrough brain implant system
Synchron Inc. secured FDA clearance for its Stentrode brain-computer interface, enabling paralyzed patients to control digital devices through neural signals…
Generative AI and digital twins revolutionize drug development with ethical and regulatory challenges
Generative AI and digital twin technology are transforming drug development, reducing trial durations by 50% and minimizing placebo groups. Recent…